KAID Health is a developer of an AI-enabled clinical analysis and provider engagement platform that aims to enhance care management through automation and comprehensive patient data utilization. The platform facilitates collaboration between healthcare providers and payers, aligning their clinical, operational, and financial objectives. By identifying gaps in care and integrating them into providers' workflows, KAID Health enables timely interventions across various clinical settings. Its capabilities include automating quality metric reporting for primary care providers, which empowers care teams to engage patients effectively. This support allows clinicians to dedicate more time to empathic partnerships with their patients, ultimately promoting better health outcomes.
Huma.AI, Inc. is a technology company based in Palo Alto, California, that focuses on knowledge automation for the pharmaceutical and healthcare industries. Incorporated in 2016, Huma.AI addresses inefficiencies caused by complex and disconnected systems that hinder data accessibility and insights. The company's platform connects disparate data silos through natural language processing, enabling users to easily access information and gain actionable insights without requiring specialized technical knowledge. By simplifying interactions with data, Huma.AI aims to enhance decision-making and operational efficiency in a sector characterized by an overwhelming volume of information.
Reveleer is a healthcare software and services company that empowers payers in all lines of business to take control over their risk adjustment and quality improvement programs. The Reveleer platform enables payers to independently execute and manage every aspect of provider outreach, retrieval, coding, abstraction and reporting – all under one single platform. Leveraging its technology, proprietary data sets, and subject matter expertise, Reveleer also assists payers with full record retrieval and review services to support financial performance and improved member outcomes.
TrekIT provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more.
Developer of clinical research software designed to accelerate timelines by automating multiple impact processes. The company's software provides complete rapid trial feasibility, electronic medical record data processing, feasibility and site selection, precision patient trial matching and care coordination, enabling clients to reduce cost increase enrollment and streamline the clinical research process.
Clinical Research IO is a health technology company that specializes in developing software for clinical research sites. The company offers an electronic source (eSource) platform that allows research investigators to create customizable templates for capturing clinical trial data using mobile devices, thereby enhancing efficiency and accuracy in the data collection process. The software includes modules for patient recruitment, scheduling, and compliance management, which feature tools for sending text reminders to patients. Additionally, Clinical Research IO integrates its eSource with a Clinical Trial Management System (CTMS) that facilitates the management of regulatory documents electronically. With offices in Boston and San Francisco, the company aims to modernize the traditionally paper-based clinical trial process.
Turbine Ltd is a biotechnology company based in Budapest, Hungary, founded in 2015. It specializes in the development of computational models that predict biological and clinical outcomes to aid in cancer drug development. Utilizing its proprietary Simulated Cell technology alongside artificial intelligence, Turbine focuses on understanding the intricate mechanisms of cancer. This approach facilitates the discovery of novel protein targets and precision biomarkers, enhancing the translation of research to patient care. The company also creates cancer combination therapies that clarify the underlying biology of diseases and personalize treatment options. By leveraging bioinformatics and network medicine, Turbine effectively simulates complex interventions, allowing for the screening of numerous drug combinations on simulated cells. This innovative process aims to provide cancer patients with low-cost and effective treatment plans.
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions.
SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.
COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.
Cecelia Health is tech-enabled diabetes and chronic disease management company that combines technology with expert clinical coaching. It aims to transform the lives and health outcomes of people with diabetes, obesity, cardiovascular disease, and other chronic conditions. Cecelia Health helps people with chronic conditions adhere to their medications and related nutrition, health, and wellness programs. During COVID-19, Cecelia Health has also been offering telehealth support to patients. It was founded in 2009 and headquartered in New York, United States.
TrekIT provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more.
Reveleer is a healthcare software and services company that empowers payers in all lines of business to take control over their risk adjustment and quality improvement programs. The Reveleer platform enables payers to independently execute and manage every aspect of provider outreach, retrieval, coding, abstraction and reporting – all under one single platform. Leveraging its technology, proprietary data sets, and subject matter expertise, Reveleer also assists payers with full record retrieval and review services to support financial performance and improved member outcomes.
Health Decisions, Inc. provides clinical research services. It offers project management, medical writing, data management, biostatistics, quality management, and regulatory compliance services. The company also provides strategic consulting and clinical services. Health Decisions, Inc. was founded in 1989 and is headquartered in Durham, North Carolina.
iQuartic, Inc. specializes in developing cloud platforms aimed at data networking and mining within the healthcare sector. The company's technology facilitates essential functions such as EHR and claims auditing, quality benchmarking, population health management, disease management, risk profiling, and revenue optimization. Key offerings include the iQ EHR Network, which integrates disparate EMR systems across various facilities; iQ EHR Auditing, which utilizes advanced analytics to identify inconsistencies in EHR data; and iQ ACO Software, designed for accountable care organizations to analyze networks and patient data comprehensively. Additional products encompass predictive modeling tools like the EHR Data Auditor, which focuses on HIV patient reporting; the Diabetes Management Scorecard; and the COPD Population Profiler, among others. These tools aim to enhance chronic disease management, predict hospital readmissions, and improve clinician profiling. Founded in 2012, iQuartic is headquartered in Boston, Massachusetts.
Reveleer is a healthcare software and services company that empowers payers in all lines of business to take control over their risk adjustment and quality improvement programs. The Reveleer platform enables payers to independently execute and manage every aspect of provider outreach, retrieval, coding, abstraction and reporting – all under one single platform. Leveraging its technology, proprietary data sets, and subject matter expertise, Reveleer also assists payers with full record retrieval and review services to support financial performance and improved member outcomes.
Forefront TeleCare, Inc. is a leading provider of HIPAA-compliant telehealth services focused on behavioral health care in the United States. Founded in 2005 and based in Novato, California, the company specializes in delivering telepsychiatry, telepsychology, and telepsychotherapy services, particularly to small and rural healthcare facilities. Forefront TeleCare offers a comprehensive solution that includes in-facility equipment, training, scheduling, and technical support, ensuring secure and reliable audio/video connections between healthcare providers and patients. The company serves a diverse client base, including skilled nursing facilities and clinics across 18 states, and collaborates with a network of psychiatrists, clinical psychologists, and psychiatric nurse practitioners. By integrating behavioral health support into the overall care team, Forefront TeleCare aims to enhance the quality of life for seniors and individuals requiring psychiatric services.
Roobrik, Inc. is an online platform founded in 2013 and based in Greensboro, North Carolina. The company specializes in providing decision-making tools designed to assist caregivers, senior care providers, and clinicians in navigating health and care choices. By offering resources that empower older adults and their families, Roobrik facilitates informed decision-making and helps users connect with various products, services, and programs to meet their needs.
COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.
Mingle Health is a company focused on Transforming healthcare through data-driven solutions.
C2Sense, Inc. specializes in the development of chemiresistive gas sensors aimed at applications in food and agriculture. The company’s sensors detect gases such as ethylene and biogenic amines at very low concentrations, facilitating the monitoring of fruit ripeness and the freshness of meat, fish, and poultry throughout the supply chain. By providing accurate data, C2Sense enables growers, shippers, distributors, retailers, and consumers to make informed decisions that help reduce food waste. Founded in 2013 as a spinout from MIT, C2Sense employs nanotechnology and advanced chemical engineering techniques to create miniaturized mobile sensing solutions. In addition to food-related applications, the company’s technology addresses challenges in rapid medical diagnostics, product authentication, environmental monitoring, and safety across various sectors. Based in Cambridge, Massachusetts, C2Sense is committed to promoting a healthier and safer world through its innovative sensing technology.
Bivarus, Inc. is a company based in Durham, North Carolina, specializing in a cloud-based analytics platform designed to enhance continuous quality improvement (CQI) and the patient experience within hospital-based outpatient services, community clinics, and group practices. Founded in 2010, Bivarus emerged from academic research that highlighted the significance of patient experience as a predictor of health outcomes. The platform provides healthcare leaders with actionable insights into the factors influencing patient experience, provider performance, and service operations, enabling real-time identification of service issues and evaluation of quality improvement initiatives. Bivarus is recognized as a CMS-approved CAHPS® partner and also offers services for assessing employee perceptions related to organizational effectiveness, culture, and safety, thereby supporting engagement across healthcare organizations. As of January 2018, Bivarus operates as a subsidiary of Press Ganey Holdings, Inc.
COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.
BC Platforms specializes in genomic data management solutions aimed at tackling significant healthcare challenges. The company offers a robust data management platform that facilitates the integration, secure analysis, and interpretation of molecular and clinical data. By combining genomics with IT, BC Platforms empowers health organizations to make informed decisions in drug development and delivery. Their systematic and standardized approach allows for efficient handling of complex health data, ultimately supporting improved outcomes in healthcare.
Bivarus, Inc. is a company based in Durham, North Carolina, specializing in a cloud-based analytics platform designed to enhance continuous quality improvement (CQI) and the patient experience within hospital-based outpatient services, community clinics, and group practices. Founded in 2010, Bivarus emerged from academic research that highlighted the significance of patient experience as a predictor of health outcomes. The platform provides healthcare leaders with actionable insights into the factors influencing patient experience, provider performance, and service operations, enabling real-time identification of service issues and evaluation of quality improvement initiatives. Bivarus is recognized as a CMS-approved CAHPS® partner and also offers services for assessing employee perceptions related to organizational effectiveness, culture, and safety, thereby supporting engagement across healthcare organizations. As of January 2018, Bivarus operates as a subsidiary of Press Ganey Holdings, Inc.
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating chronic pain while addressing the concerns of prescription drug abuse. The company utilizes its patented DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release profiles and safety of medications despite potential misuse methods such as chewing or crushing. Collegium's product lineup includes Xtampza ER, an extended-release oral formulation of oxycodone designed to deter abuse, as well as Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol respectively, for managing severe pain and acute pain in adults. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions for patients with chronic pain, utilizing formulation improvements backed by strong intellectual property protections.
G-Form, LLC is a manufacturer of protective gear for athletic and consumer electronic applications, established in 2010 and headquartered in Providence, Rhode Island. The company's product lineup includes protective equipment for various sports, such as knee, elbow, and shin pads, as well as specialized items like shorts, brake hood overgrips, and saddle gel kits. Additionally, G-Form produces protective solutions for electronic devices, including gear for laptops, iPads, iPhones, and tablets. The company distributes its products through a network of retailers and distributors both domestically and internationally, in addition to offering online sales within the United States. G-Form is recognized for its commitment to creating protective and comfortable athletic equipment.
Avhana Health Inc. provides an application to simplify the healthcare provider workflow by offering the latest guidelines, actionable recommendations, and performance metrics—directly in their EHR. Its application features a dashboard for pre-visit planning, patient-specific recommendations for care, corresponding order suggestions that submit to the EHR, and a dashboard for tracking provider activity and performance. The company was founded in 2014 and is based in Baltimore, Maryland.
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world.
With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world.
With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.
PreCision Dermatology is a fully-integrated dermatology company with a mission to deliver innovative therapies to doctors and patients that demonstrably improve the care of skin. PreCision Dermatology is expanding rapidly through internally generated innovation, acquisitions, in-licensing, and co-marketing opportunities.
Histogenics Corporation, based in Waltham, Massachusetts, specializes in regenerative medicine with a focus on developing therapies for musculoskeletal conditions. Founded in 2000, the company aims to create innovative solutions for cartilage damage and joint function restoration. Its primary product candidate, NeoCart®, is a tissue implant designed to regenerate healthy cartilage and improve orthopedic outcomes, particularly for knee injuries. By integrating expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors, Histogenics seeks to address degenerative diseases and enhance patient recovery through its advanced regenerative medicine platform. In 2019, Histogenics was acquired by Ocugen, Inc. in a reverse merger transaction.
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating chronic pain while addressing the concerns of prescription drug abuse. The company utilizes its patented DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release profiles and safety of medications despite potential misuse methods such as chewing or crushing. Collegium's product lineup includes Xtampza ER, an extended-release oral formulation of oxycodone designed to deter abuse, as well as Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol respectively, for managing severe pain and acute pain in adults. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions for patients with chronic pain, utilizing formulation improvements backed by strong intellectual property protections.
NuVox is a provider of voice and data network communications, offering a range of managed services to businesses across the United States. The company's services include broadband access, conference calling, data security and backup, voicemail, and web hosting. By focusing on these essential communication and data solutions, NuVox aims to meet the diverse needs of its business clients, ensuring reliable connectivity and efficient management of their communication infrastructure.
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world.
With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.
SensorLogic specializes in machine-to-machine (M2M) application hosting and offers a platform-as-a-service (PaaS) that delivers customizable M2M solutions integrated with a nationwide GSM/GPRS network. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with additional network services. By focusing on cloud-based M2M applications, SensorLogic enables businesses to efficiently manage and optimize their operations through advanced technology solutions.
Nexidia Inc. specializes in developing dialogue and audio analysis technologies designed to optimize audio and video media. The company's product offerings include Nexidia Interaction Analytics for analyzing multichannel contact center interactions, Nexidia Capture for call recording and storage, and real-time monitoring solutions such as Nexidia Scan and Agent Assist. Additionally, Nexidia provides tools like Dialogue Search for content discovery, QC for automating closed caption verification, and Comply for video program automation. Its offerings extend to Audio Discovery OnDemand for sound recording analysis, and various search solutions for managing large volumes of audio and video content. Nexidia also delivers consulting, training, and support services across multiple industries, including communications, healthcare, and media. Founded in 2000 and based in Atlanta, Georgia, Nexidia was previously known as Fast-Talk Communications, Inc. and became a subsidiary of NICE Systems Ltd. in 2016.
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.
Coapt Systems, Inc. specializes in the design, development, and manufacturing of bio-absorbable implants intended for soft tissue fixation in facial cosmetic surgery. Its product offerings include various fixation devices such as the ENDOTINE Forehead 3.0 and ENDOTINE Midface ST 4.5, which are employed in procedures like forehead lifts, brow lifts, and midface suspensions. The company also provides surgical instruments and tools, including insertion kits and manual drills, to facilitate the use of its implants. Coapt Systems aims to support surgeons in achieving effective and secure tissue fixation during surgical procedures, enhancing outcomes for patients undergoing cosmetic interventions.
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.
MedAptus, Inc. is a healthcare technology company that specializes in clinical workforce and workflow solutions. Its offerings include a range of charge capture technologies, such as Pro Charge Capture, which assists physicians and administrative staff in managing billing in hospitalist groups and multi-specialty clinics. The company also provides various editions tailored to different healthcare environments, including inpatient settings, outpatient clinics, and academic medical centers. Notable solutions include Assign for Rounding Providers, which optimizes patient assignments based on provider schedules, and MedAptus Collaborate, which facilitates secure communication among caregivers. By streamlining administrative tasks and enhancing collaboration, MedAptus aims to improve clinical operations for hospitals and healthcare organizations. Founded in 1999 and based in Boston, Massachusetts, the company operates as a subsidiary of Volaris Group Inc.
Histogenics Corporation, based in Waltham, Massachusetts, specializes in regenerative medicine with a focus on developing therapies for musculoskeletal conditions. Founded in 2000, the company aims to create innovative solutions for cartilage damage and joint function restoration. Its primary product candidate, NeoCart®, is a tissue implant designed to regenerate healthy cartilage and improve orthopedic outcomes, particularly for knee injuries. By integrating expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors, Histogenics seeks to address degenerative diseases and enhance patient recovery through its advanced regenerative medicine platform. In 2019, Histogenics was acquired by Ocugen, Inc. in a reverse merger transaction.
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating chronic pain while addressing the concerns of prescription drug abuse. The company utilizes its patented DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release profiles and safety of medications despite potential misuse methods such as chewing or crushing. Collegium's product lineup includes Xtampza ER, an extended-release oral formulation of oxycodone designed to deter abuse, as well as Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol respectively, for managing severe pain and acute pain in adults. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions for patients with chronic pain, utilizing formulation improvements backed by strong intellectual property protections.
SensorLogic specializes in machine-to-machine (M2M) application hosting and offers a platform-as-a-service (PaaS) that delivers customizable M2M solutions integrated with a nationwide GSM/GPRS network. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with additional network services. By focusing on cloud-based M2M applications, SensorLogic enables businesses to efficiently manage and optimize their operations through advanced technology solutions.
Arthrosurface, Inc. is an orthopedic medical device company that specializes in minimally invasive joint resurfacing systems. Founded in 2001 and based in Franklin, Massachusetts, the company develops surgical alternatives aimed at treating orthopedic joint diseases, particularly focusing on articular cartilage damage in major joints such as knees, hips, shoulders, and toes. Arthrosurface's product offerings include surface implant curvatures designed to address conditions caused by trauma, injury, and arthritis. The company has introduced a range of products over the years, including resurfacing solutions for the patellofemoral joint, partial knees, and a total shoulder system. By utilizing less invasive technologies, Arthrosurface aims to enable patients to maintain active lifestyles while providing surgeons with innovative tools. Its products are distributed through a network of sales representatives both in the United States and internationally. As of early 2020, Arthrosurface operates as a subsidiary of Anika Therapeutics, Inc.
MedAptus, Inc. is a healthcare technology company that specializes in clinical workforce and workflow solutions. Its offerings include a range of charge capture technologies, such as Pro Charge Capture, which assists physicians and administrative staff in managing billing in hospitalist groups and multi-specialty clinics. The company also provides various editions tailored to different healthcare environments, including inpatient settings, outpatient clinics, and academic medical centers. Notable solutions include Assign for Rounding Providers, which optimizes patient assignments based on provider schedules, and MedAptus Collaborate, which facilitates secure communication among caregivers. By streamlining administrative tasks and enhancing collaboration, MedAptus aims to improve clinical operations for hospitals and healthcare organizations. Founded in 1999 and based in Boston, Massachusetts, the company operates as a subsidiary of Volaris Group Inc.
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.
Information management company providing consultation and business service solutions for information centers
Arthrosurface, Inc. is an orthopedic medical device company that specializes in minimally invasive joint resurfacing systems. Founded in 2001 and based in Franklin, Massachusetts, the company develops surgical alternatives aimed at treating orthopedic joint diseases, particularly focusing on articular cartilage damage in major joints such as knees, hips, shoulders, and toes. Arthrosurface's product offerings include surface implant curvatures designed to address conditions caused by trauma, injury, and arthritis. The company has introduced a range of products over the years, including resurfacing solutions for the patellofemoral joint, partial knees, and a total shoulder system. By utilizing less invasive technologies, Arthrosurface aims to enable patients to maintain active lifestyles while providing surgeons with innovative tools. Its products are distributed through a network of sales representatives both in the United States and internationally. As of early 2020, Arthrosurface operates as a subsidiary of Anika Therapeutics, Inc.
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world.
With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.
Xconomy, Inc. is a media company that delivers business, life sciences, and technology news across various U.S. cities, including Boston, Seattle, San Diego, and New York. Established in 2007 and headquartered in Cambridge, Massachusetts, Xconomy provides insights into local personalities, companies, and technological trends, catering to an audience that includes entrepreneurs, investors, legal professionals, and university officials. The company is recognized for its role in covering the exponential economy, which is defined by rapid technological growth and its impact on productivity and economic development. Xconomy disseminates its content through a network of localized news sites, events, and conferences, ensuring that its audience remains informed about the latest developments in the business and technology sectors. Additionally, Xconomy offers advertising opportunities, including banner ads and underwriting programs, to enhance engagement with its content.
SensorLogic specializes in machine-to-machine (M2M) application hosting and offers a platform-as-a-service (PaaS) that delivers customizable M2M solutions integrated with a nationwide GSM/GPRS network. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with additional network services. By focusing on cloud-based M2M applications, SensorLogic enables businesses to efficiently manage and optimize their operations through advanced technology solutions.
Coapt Systems, Inc. specializes in the design, development, and manufacturing of bio-absorbable implants intended for soft tissue fixation in facial cosmetic surgery. Its product offerings include various fixation devices such as the ENDOTINE Forehead 3.0 and ENDOTINE Midface ST 4.5, which are employed in procedures like forehead lifts, brow lifts, and midface suspensions. The company also provides surgical instruments and tools, including insertion kits and manual drills, to facilitate the use of its implants. Coapt Systems aims to support surgeons in achieving effective and secure tissue fixation during surgical procedures, enhancing outcomes for patients undergoing cosmetic interventions.
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating chronic pain while addressing the concerns of prescription drug abuse. The company utilizes its patented DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release profiles and safety of medications despite potential misuse methods such as chewing or crushing. Collegium's product lineup includes Xtampza ER, an extended-release oral formulation of oxycodone designed to deter abuse, as well as Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol respectively, for managing severe pain and acute pain in adults. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions for patients with chronic pain, utilizing formulation improvements backed by strong intellectual property protections.
Nexidia Inc. specializes in developing dialogue and audio analysis technologies designed to optimize audio and video media. The company's product offerings include Nexidia Interaction Analytics for analyzing multichannel contact center interactions, Nexidia Capture for call recording and storage, and real-time monitoring solutions such as Nexidia Scan and Agent Assist. Additionally, Nexidia provides tools like Dialogue Search for content discovery, QC for automating closed caption verification, and Comply for video program automation. Its offerings extend to Audio Discovery OnDemand for sound recording analysis, and various search solutions for managing large volumes of audio and video content. Nexidia also delivers consulting, training, and support services across multiple industries, including communications, healthcare, and media. Founded in 2000 and based in Atlanta, Georgia, Nexidia was previously known as Fast-Talk Communications, Inc. and became a subsidiary of NICE Systems Ltd. in 2016.
Athenix is a leader in agricultural and industrial biotechnology. They have built the infrastructure necessary to discover new genes and to develop them into products that meet real customer needs.
GlycoFi Inc.
Series C in 2005
GlycoFi is a biotech firm that develops biotherapeutics based on the glycan optimization technology. The firm aims to develop its own pipeline of therapeutic proteins and team with other drug-makers to develop products. GlycoFi has developed a protein manufacturing process using yeast-based glycolysation where the resulting proteins can be used in drug development. GlycoFi was incorporated in 2000 and is based in Lebanon, New Hampshire. As of June 6, 2006, GlycoFi, Inc. operates as a subsidiary of Merck & Co. Inc.
Nexidia Inc. specializes in developing dialogue and audio analysis technologies designed to optimize audio and video media. The company's product offerings include Nexidia Interaction Analytics for analyzing multichannel contact center interactions, Nexidia Capture for call recording and storage, and real-time monitoring solutions such as Nexidia Scan and Agent Assist. Additionally, Nexidia provides tools like Dialogue Search for content discovery, QC for automating closed caption verification, and Comply for video program automation. Its offerings extend to Audio Discovery OnDemand for sound recording analysis, and various search solutions for managing large volumes of audio and video content. Nexidia also delivers consulting, training, and support services across multiple industries, including communications, healthcare, and media. Founded in 2000 and based in Atlanta, Georgia, Nexidia was previously known as Fast-Talk Communications, Inc. and became a subsidiary of NICE Systems Ltd. in 2016.
Novalar Pharmaceuticals
Series C in 2005
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.
Netifice Communications is redefining how Managed Service Providers deliver secure IP data and voice communication services.
Arthrosurface, Inc. is an orthopedic medical device company that specializes in minimally invasive joint resurfacing systems. Founded in 2001 and based in Franklin, Massachusetts, the company develops surgical alternatives aimed at treating orthopedic joint diseases, particularly focusing on articular cartilage damage in major joints such as knees, hips, shoulders, and toes. Arthrosurface's product offerings include surface implant curvatures designed to address conditions caused by trauma, injury, and arthritis. The company has introduced a range of products over the years, including resurfacing solutions for the patellofemoral joint, partial knees, and a total shoulder system. By utilizing less invasive technologies, Arthrosurface aims to enable patients to maintain active lifestyles while providing surgeons with innovative tools. Its products are distributed through a network of sales representatives both in the United States and internationally. As of early 2020, Arthrosurface operates as a subsidiary of Anika Therapeutics, Inc.
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world.
With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.
FastChannel provides innovative, technology-based solutions to help advertisers and agencies work faster, smarter and more competitively. Through the FastChannel Intelligence and Control platform customers leverage an integrated suite of intelligence and workflow tools designed specifically for the advertising industry—competitor tracking, creative and production resourcing, broadcast verification, and digital asset management. The company also features an online media distribution network, with more than 5,000 advertisers and agencies, and 21,000 online broadcast and publishing destinations.
SensorLogic specializes in machine-to-machine (M2M) application hosting and offers a platform-as-a-service (PaaS) that delivers customizable M2M solutions integrated with a nationwide GSM/GPRS network. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with additional network services. By focusing on cloud-based M2M applications, SensorLogic enables businesses to efficiently manage and optimize their operations through advanced technology solutions.
Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.
Tropos Networks designs and supplies technology for building extensive wireless broadband networks suitable for various applications, including smart grid and outdoor industrial use. Their products allow network operators, service providers, and government entities to establish reliable metro-scale Wi-Fi networks without the need for wired connections at each node, significantly reducing installation and operational costs. The company's MetroMesh OS enhances network performance through features such as predictive wireless routing, adaptive mesh connectivity, and self-organizing capabilities. This innovative approach provides users with broad and efficient wireless data coverage in diverse environments, making Tropos a key player in the development of scalable and secure wireless infrastructure.
Continuum Photonics specializes in the development of optical layer connectivity products designed for managing and switching fiber-based optical networks. The company focuses on providing manufacturers of optical networking equipment with innovative subsystems that enhance bandwidth capabilities and facilitate revenue-generating services at reduced costs. Key offerings include single-mode and multi-mode optical matrix switches, carrier optical monitor switches, and latching switches. Continuum Photonics is also advancing a novel photonic switch aimed at addressing various challenges related to the delivery and management of optically-transported bandwidth, which underscores its commitment to creating operational and economic efficiencies in the optical networking sector.
CombinatoRx
Series C in 2004
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.
Zalicus Inc., based in Cambridge, Massachusetts, is a biopharmaceutical company focused on developing innovative drug candidates for the treatment of pain and inflammation. The company specializes in ion-channel modulation, which involves creating therapeutics that selectively block ion channels in neuronal cells to disrupt pain signal transmission. Zalicus has dedicated significant resources to drug discovery technology, conducting both preclinical and clinical trials, and protecting its intellectual property. Notably, the company received FDA approval for Exalgo, an extended-release formulation of hydromorphone, designed for managing moderate to severe pain in patients who are opioid tolerant. Additionally, Zalicus aims to discover and develop novel-target pain therapies, including calcium channel modulators for both chronic and acute inflammatory pain. The company's evolution includes a merger with Neuromed Pharmaceuticals, enhancing its capabilities in pain management.
Athenix is a leader in agricultural and industrial biotechnology. They have built the infrastructure necessary to discover new genes and to develop them into products that meet real customer needs.
Information management company providing consultation and business service solutions for information centers
Galt is an international leader in helping clients manage risk through information. Galt's evidence-based solutions integrate the recognized expertise of its medical and scientific personnel with innovative technologies to ensure timely answers to clients' critical questions. This integrated approach allows Galt to deliver medical risk management and communication strategies that address the benefits and risks associated with the full range of medical therapies and interventions. Galt supports more than 70 pharmaceutical, medical device and biotechnology companies, as well as contract research organizations (CRO) and research institutions located throughout the U.S. and Europe
Novalar Pharmaceuticals
Series B in 2003
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.
MedAptus, Inc. is a healthcare technology company that specializes in clinical workforce and workflow solutions. Its offerings include a range of charge capture technologies, such as Pro Charge Capture, which assists physicians and administrative staff in managing billing in hospitalist groups and multi-specialty clinics. The company also provides various editions tailored to different healthcare environments, including inpatient settings, outpatient clinics, and academic medical centers. Notable solutions include Assign for Rounding Providers, which optimizes patient assignments based on provider schedules, and MedAptus Collaborate, which facilitates secure communication among caregivers. By streamlining administrative tasks and enhancing collaboration, MedAptus aims to improve clinical operations for hospitals and healthcare organizations. Founded in 1999 and based in Boston, Massachusetts, the company operates as a subsidiary of Volaris Group Inc.
Nexidia Inc. specializes in developing dialogue and audio analysis technologies designed to optimize audio and video media. The company's product offerings include Nexidia Interaction Analytics for analyzing multichannel contact center interactions, Nexidia Capture for call recording and storage, and real-time monitoring solutions such as Nexidia Scan and Agent Assist. Additionally, Nexidia provides tools like Dialogue Search for content discovery, QC for automating closed caption verification, and Comply for video program automation. Its offerings extend to Audio Discovery OnDemand for sound recording analysis, and various search solutions for managing large volumes of audio and video content. Nexidia also delivers consulting, training, and support services across multiple industries, including communications, healthcare, and media. Founded in 2000 and based in Atlanta, Georgia, Nexidia was previously known as Fast-Talk Communications, Inc. and became a subsidiary of NICE Systems Ltd. in 2016.
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.
Protein Forest, Inc. develops, manufactures and markets instruments, consumables, and software products to scientists for protein separation and bioanalysis applications in the United States and internationally. The company offers digital ProteomeChip (dPC), which fractionates and concentrates proteins or peptides by isoelectric focusing for mass spec analysis and western blotting. Its solutions include dPC fractionator, which runs separate samples under controlled temperature, voltage, and mixing; dPC fractionator workflow, which integrates existing mass spectroscopy workflows; dPC PlugHarvestor, which allows users to select and group a set of pH gel plugs into a tube or a microplate; and bioinformatics software products. The company serves scientists in life science, drug discovery, pharmaceutical, biotech, and diagnostic industries. Protein Forest, Inc. was founded in 2002 and is based in Lexington, Massachusetts.
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating chronic pain while addressing the concerns of prescription drug abuse. The company utilizes its patented DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release profiles and safety of medications despite potential misuse methods such as chewing or crushing. Collegium's product lineup includes Xtampza ER, an extended-release oral formulation of oxycodone designed to deter abuse, as well as Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol respectively, for managing severe pain and acute pain in adults. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions for patients with chronic pain, utilizing formulation improvements backed by strong intellectual property protections.
PHT Corporation is a leading provider of electronic patient-reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers the LogPad and StudyPad Systems, which enhance data quality and facilitate efficient data collection. Additionally, PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to trial data, enabling informed decision-making. By leveraging these technologies, biopharmaceutical and medical device companies can obtain more comprehensive data and accelerate their trial processes, ultimately contributing to the success of clinical studies.
Arthrosurface, Inc. is an orthopedic medical device company that specializes in minimally invasive joint resurfacing systems. Founded in 2001 and based in Franklin, Massachusetts, the company develops surgical alternatives aimed at treating orthopedic joint diseases, particularly focusing on articular cartilage damage in major joints such as knees, hips, shoulders, and toes. Arthrosurface's product offerings include surface implant curvatures designed to address conditions caused by trauma, injury, and arthritis. The company has introduced a range of products over the years, including resurfacing solutions for the patellofemoral joint, partial knees, and a total shoulder system. By utilizing less invasive technologies, Arthrosurface aims to enable patients to maintain active lifestyles while providing surgeons with innovative tools. Its products are distributed through a network of sales representatives both in the United States and internationally. As of early 2020, Arthrosurface operates as a subsidiary of Anika Therapeutics, Inc.
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world.
With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.
Entigo specializes in enterprise warranty chain management solutions, providing businesses with tools to streamline warranty processing. Its primary offerings include Entigo Warranty, which facilitates the management of warranty claims, and Entigo Catalyst, designed for strategic assessments of existing warranty operations. The company also offers a range of services such as project management, implementation consulting, and systems integration. These solutions aim to automate the registration and claims process, reduce error rates, and enhance analytics for informed decision-making, ultimately improving product quality and minimizing warranty costs. Entigo's systems are tailored to meet the needs of Fortune 500 manufacturers across various sectors, including automotive, aerospace, and industrial equipment. Founded in 1995 and headquartered in Exton, Pennsylvania, Entigo is committed to optimizing warranty processes and ensuring seamless integration with warranty chain partners.
Tropos Networks designs and supplies technology for building extensive wireless broadband networks suitable for various applications, including smart grid and outdoor industrial use. Their products allow network operators, service providers, and government entities to establish reliable metro-scale Wi-Fi networks without the need for wired connections at each node, significantly reducing installation and operational costs. The company's MetroMesh OS enhances network performance through features such as predictive wireless routing, adaptive mesh connectivity, and self-organizing capabilities. This innovative approach provides users with broad and efficient wireless data coverage in diverse environments, making Tropos a key player in the development of scalable and secure wireless infrastructure.
Private Equity Round in 2002
NuVox is a provider of voice and data network communications, offering a range of managed services to businesses across the United States. The company's services include broadband access, conference calling, data security and backup, voicemail, and web hosting. By focusing on these essential communication and data solutions, NuVox aims to meet the diverse needs of its business clients, ensuring reliable connectivity and efficient management of their communication infrastructure.
Novalar Pharmaceuticals
Series A in 2002
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.
Nexidia Inc. specializes in developing dialogue and audio analysis technologies designed to optimize audio and video media. The company's product offerings include Nexidia Interaction Analytics for analyzing multichannel contact center interactions, Nexidia Capture for call recording and storage, and real-time monitoring solutions such as Nexidia Scan and Agent Assist. Additionally, Nexidia provides tools like Dialogue Search for content discovery, QC for automating closed caption verification, and Comply for video program automation. Its offerings extend to Audio Discovery OnDemand for sound recording analysis, and various search solutions for managing large volumes of audio and video content. Nexidia also delivers consulting, training, and support services across multiple industries, including communications, healthcare, and media. Founded in 2000 and based in Atlanta, Georgia, Nexidia was previously known as Fast-Talk Communications, Inc. and became a subsidiary of NICE Systems Ltd. in 2016.
TechSmart.com (the "Company"), formed in April 1997 under the name Linx Technologies, offers original equipment manufacturers, lessors, retailers, e-tailers and large corporations a web-based asset recovery solution ("Assets into Money") to effectively manage and resell their returned, refreshed, off-lease and overstock office technology assets ("recovered assets"). These businesses, which They call SmartPartners, send their technology assets to TechSmart.com's processing facilities where the assets are audited, tested, cleaned, packaged and remarketed through the Company's web site. Historically, businesses with recovered assets operated an inefficient in-house program in conjunction with a multi-tiered chain of "mom and pop" refurbishers, brokers, resellers and service providers. Because recovered asset management is not a core competency of these asset owners, they incurred excessive processing costs and achieved sales far below fair market value.
WebCT, Inc. is a prominent provider of e-learning solutions tailored for higher education institutions, colleges, and universities. Founded with the vision of creating a flexible and integrated learning environment, WebCT aims to enhance student engagement through technology that promotes inquiry, discourse, and collaboration. The company offers a comprehensive suite of learning management solutions that seamlessly integrate advanced pedagogical tools with existing campus infrastructure. In addition to its core products, WebCT provides various support services, including technical assistance, professional development, and hosting, which collectively simplify and enrich the educational experience for students worldwide. Through its innovative solutions, WebCT is committed to advancing educational excellence in the higher education sector.
PhotonEx is a prominent event in the UK, focusing on photonics and light technologies. It serves as a platform to showcase innovations and advancements in this field, bringing together industry experts, researchers, and businesses to discuss and explore the latest developments. In addition to organizing this event, PhotonEx is involved in the development of smart photonic systems aimed at enhancing public telecommunications networks. By integrating cutting-edge photonic technologies, the company aims to improve the efficiency and performance of telecommunications infrastructure. Through its initiatives, PhotonEx plays a crucial role in promoting the growth and application of photonics in various sectors.
Athenix is a leader in agricultural and industrial biotechnology. They have built the infrastructure necessary to discover new genes and to develop them into products that meet real customer needs.
Verio Inc. is a provider of online business solutions, primarily catering to small and medium-sized businesses. The company offers a range of services, including shared website hosting, domain name registration, VPS hosting, and website design. Additionally, Verio provides SSL certificates, Microsoft Exchange services, and various marketing solutions such as search engine optimization and email marketing. It operates through a global network of channel partners, enabling access to its services in over 200 countries. Verio also emphasizes customer support, offering assistance via phone, email, and online chat. Formerly known as WorldNet Access, Inc., Verio was established in 1996 and is based in Orem, Utah, with data centers in Boston, Massachusetts. It operates as a subsidiary of NTT Communications, leveraging their infrastructure to deliver reliable and scalable internet services.
PartyCity offers consumers a supply chain that provides store locations, company history, press releases, and stock quotes.
MedAptus, Inc. is a healthcare technology company that specializes in clinical workforce and workflow solutions. Its offerings include a range of charge capture technologies, such as Pro Charge Capture, which assists physicians and administrative staff in managing billing in hospitalist groups and multi-specialty clinics. The company also provides various editions tailored to different healthcare environments, including inpatient settings, outpatient clinics, and academic medical centers. Notable solutions include Assign for Rounding Providers, which optimizes patient assignments based on provider schedules, and MedAptus Collaborate, which facilitates secure communication among caregivers. By streamlining administrative tasks and enhancing collaboration, MedAptus aims to improve clinical operations for hospitals and healthcare organizations. Founded in 1999 and based in Boston, Massachusetts, the company operates as a subsidiary of Volaris Group Inc.
Sensitech® is a world leader in supply chain visibility. Their innovative monitoring products and services help to maintain the quality, integrity and security of their customers' valuable products at every step in their journey, all around the world. For more than 25 years, leading companies in the food, pharmaceutical, industrial, consumer goods, and other industries have relied on Sensitech to help protect their products—and their bottom lines.
Geyser Networks
Venture Round in 2000
As of October 12, 2001, Geyser Networks, Inc. went out of business. The company provides multi service optical solutions for the next generation optical networks. It designs and markets high-performance networking appliances including switching and routing systems. The company has developed the FlexBand™ technology, which integrates n x VT1.5 virtual concatenation, Dynamic Bandwidth Allocation (DBA) and traffic management to generate multiple TDM-like pipes for various applications. Geyser's product using this technology include: Geyser OSM 4800™ (Optical Service Manager) combines critical network elements (i.e. DWDM, MPLS Router, Ethernet Switch, IAD, etc.) into one metropolitan area networking platform; and Geyser Networks MetroView™ Network Manager System (NMS) providing a customer services management system for optical networks, linking business-level software for billing, alarm correlation, and northbound functionalities. The company was founded in 1999 and is based in Sunnyvale, California.
PHT Corporation is a leading provider of electronic patient-reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers the LogPad and StudyPad Systems, which enhance data quality and facilitate efficient data collection. Additionally, PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to trial data, enabling informed decision-making. By leveraging these technologies, biopharmaceutical and medical device companies can obtain more comprehensive data and accelerate their trial processes, ultimately contributing to the success of clinical studies.
Totality specializes in application and infrastructure management services tailored for large-scale e-commerce websites that demand mass customization. The company addresses essential needs of its clients by offering solutions that ensure high performance and visibility into business processes. Through its focused service level agreements, Totality aims to deliver guaranteed business outcomes, effectively supporting the operational requirements of its customers.
InfoImage Inc. provides software solutions that automate business processes. The Company offers a variety of software tools and consulting services for use in streamlining office processes. InfoImage's products and services utilize object technology, groupware, intranets, and the Internet.
V-Span is a prominent provider of video-oriented collaboration and conferencing services, catering to both enterprise and channel markets. The company offers a comprehensive portfolio that includes audio, video, web, and streaming solutions tailored for various business applications such as human resources, training, marketing, product development, and sales. V-Span supports its customers through online self-service options, experienced full-service call centers, and a diversified global network, enabling effective electronic meetings, events, and training sessions.